AIxMed was founded by a cross-disciplinary team of senior IT professionals and clinical medicine experts. AIxMed develops various applications for clinical and laboratory cytology through advanced AI and deep learning computer vision technology. AIxMed was founded in Silicon Valley, USA, and is jointly supported by professional investment institutions and angel investors from the United States and Taiwan. Through its subsidiaries in the United States and Taiwan, AIxMed has in-depth collaborations with multiple medical centers, research institutions, and advanced cytology-related industries in both countries.